Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — August 2022

Genmab — August 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #901

    Godmorgen. 🙂

    1 Reply Last reply
    0
    • P Offline
      P Offline
      ProinvestorNEWS
      wrote on sidst redigeret af
      #902

      Asien: Pæne stigninger inden central amerikansk monetær tale https://www.proinvestor.com/investornyt/871548/asien-paene-stigninger-inden-central-amerikansk-monetaer-tale

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #903

        Fredagens aviser med Mærsk, Ambu og Parken https://www.proinvestor.com/investornyt/871549/fredagens-aviser-med-maersk-ambu-og-parken

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #904

          Tak gentogen. Nej det kan undre at de ignorerer lige netop Tecvayli, som har været meget omtalt og rost.

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #905

            Aktier/tendens: SAS i fokus - markedet venter grøn åbning https://www.proinvestor.com/investornyt/871564/aktier-tendens-sas-i-fokus-markedet-venter-gron-abning

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #906

              HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1010467 "The bispecific PGT121/anti-CD3 is generated in the Duobody platform" Could this have anything to do with the old Gilead deal?

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #907

                I mean this one 'Genmab Enters Commercial License Agreement with Gilead for DuoBody(R) Technology' https://www.benzinga.com/pressreleases/16/08/g8333363/genmab-enters-commercial-license-agreement-with-gilead-for-duobody-r-te

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #908

                  Ublituximab did not reduce worsening of disability in the clinical trial. This is a serious drawback compared to ocrelizumab and ofatumumab https://twitter.com/AngelPSempere/status/1562867441990275073

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #909

                    But the deal with Gilead was stopped years ago

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #910

                      ok, thanks, i could't remember it. any idea what it could be then?

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        peter12
                        wrote on sidst redigeret af
                        #911

                        The Gilead deal was
                        still mentioned at the IPO a couple of years ago

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          peter12
                          wrote on sidst redigeret af
                          #912

                          We currently have four commercial partners for the DuoBody technology, Janssen, BioNTech, Novo Nordisk A/S, or Novo Nordisk, and Gilead Sciences, Inc., or Gilead Science https://www.sec.gov/Archives/edgar/data/1434265/000104746919003334/a2238822zf-1.htm

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #913

                            Spørgsmål til Q&A er mere end velkommen.

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #914

                              From the 2019 report: Q3: Two antibody research programs at Gilead Sciences, Inc.,
                              which incorporated Genmab’s DuoBody technology, were
                              concluded and the underlying Research Evaluation Agreements, signed in 2014 and 2016, were terminated.

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Sukkeralf
                                wrote on sidst redigeret af
                                #915

                                Page 44

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #916

                                  https://ir.genmab.com/static-files/3d726b68-34c3-4af7-9135-ec060e9ab860

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #917

                                    Q&A med Adam Stensberg fra Zealand Pharma starter kl. 15. Tilmelding her: https://www.proinvestor.com/index.php?p=q-and-a&groupid=152

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #918

                                      a bit of a mysterie then. I mean, we have seen articles on Enapotamab after it was scratched, so that is not impossible, articles on failed studies can also help science, but the study was funded by Gilead Sciences and the authors thank Rik Rademaker, Rick Hibbert and Janine Schuurman from Genmab for advice on the DuoBody technology platform.

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #919

                                        Yes but it could still just be for research purposes

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #920

                                          USA/lukning: Powell sendte Wall Street ud i blodbad med høge-ord https://www.proinvestor.com/investornyt/871929/usa-lukning-powell-sendte-wall-street-ud-i-blodbad-med-hoge-ord

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper